The effectiveness of endoscopic sphenopalatine ganglion block in management of postoperative pain after septal surgery

2019 ◽  
Vol 9 (12) ◽  
pp. 1521-1525 ◽  
Author(s):  
Nur Yücel Ekici ◽  
Sedat Alagöz
2019 ◽  
Vol 10 ◽  
pp. 215265671882128 ◽  
Author(s):  
Ahmad Rezaeian ◽  
Seyed Mostafa Hashemi ◽  
Zeinab Sadat Dokhanchi

Background Postoperative pain is one of the most complications in endoscopic sinus surgery. We aimed to evaluate the effect of the sphenopalatine ganglion block (SPGB) with bupivacaine on postoperative pain in patients undergoing endoscopic sinus surgery. Methods and Materials: In this clinical trial, 40 patients who indicated functional endoscopic sinus surgery were selected and then divided into 2 parallel groups as intervention and control. The intervention group was received 1.5 mL of bupivacaine 0.5% (injected to sphenopalatine ganglion) and while control was injected 1.5 mL of normal saline at the same injection site. Also, the visual analogue scale (VAS) was recorded immediately after anesthesia, along with 6, 12, 24, 48 h, 7 days, and 21 days after the operation for all patients. Results Immediately after anesthesia, as well as 6, 12, and 24 h after the operation, VAS in the intervention group was significantly lower than in the control group ( P < .05, for all). However, there were no significant differences between the 2 groups regarding VAS 48 h as well as 7 and 21 days after surgery ( P > .05, for both). Also, the rescue analgesia in the intervention group was significantly lower than in the control group ( P = .01). Conclusion SPGB with bupivacaine 0.5% (1.5 mL) was a simple, effective, safe, and noninvasive method for the management of postoperative pain in the patients undergoing endoscopic sinus surgery.


2020 ◽  
Vol 129 (7) ◽  
pp. 722-726
Author(s):  
Nazan Degirmenci ◽  
Abdullah Ozdem ◽  
Harun Uysal ◽  
Pelin Sen ◽  
Erol Senturk ◽  
...  

Objectives: This study aimed to evaluate the effect of preoperative sphenopalatine ganglion block (SPBG) on the postoperative pain (POP) in patients undergoing septorhinoplasty (SRP). Methods: A retrospective cohort study was performed. A total of 42 patients that had received septorhinoplasty included in the study. The patients that had received SPBG before the surgery included in the Block group (n:20) and the patients that had not received SPBG before the surgery included in the Control group (n:22). POP was questioned with a numeric rating scale (NRS) at the 30th minute (t1), 1st hour (t2), 4th hour (t3), 12th hour (t4), and 24th hour (t5) and noted. The intraoperative details and the dose of the postoperative rescue analgesics were also noted. Results: The average dose of Paracetamol that was used in the postoperative first 24 hours was 500 mg in the Block group and 1363 mg in the Control group, and the difference was statistically significant ( P = .001). The average dose of Tramadol was 0 mg in the Block group and 45 mg in the Control group, and the difference was statistically significant ( P = .001). There was a statistically significant difference among the groups with respect to NRS in the first 24 hours postoperatively ( P < .05). The number of the patients requiring rescue analgesics was lower in the Block group than the Control group. The difference was statistically significant at the t1, t2, and t5 time intervals ( P > .05). Conclusions: Preoperative SPGB is an effective option to reduce POP and the need for rescue analgesics for patients undergoing SRP. Clinical trial number: NCT04020393


Author(s):  
Meredith Busman ◽  
Tiffany Fleeger ◽  
Erin Leach ◽  
Natalie Payne ◽  
Andrew Nguyen ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document